CRUSHing Lab Fraud: Three Myths that Derail Real Reform

Leeza Osipenko Ekaterina Cleary Julie Egginton By JULIE EGGINGTON, EKATERINA CLEARY & LEEZA OSIPENKO When CMS issued its Request for Information under the Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative in February, it zeroed in on a long-festering problem: fraud, waste, and abuse in laboratory testing, especially in genetic and molecular diagnostics. The laboratory…

Read More

Does biosimilar entry reduce cost for patients?

Biosimilars aim to be lower cost options for biologic therapies after loss of exclusivity. A key question is whether these cost savings get passed through to patients via lower out-of-pocket costs. A paper by Dayer et al. (2026) aims to answer this question using 2011-2023 Merative MarketScan Commercial claims data. The authors observed: …significant patient…

Read More

Is the Atrium-WakeMed Merger Already Hitting a Wall?

A proposed merger between Atrium Health and WakeMed Health is facing an early delay, with county commissioners having postponed a key vote over transparency concerns. State officials are warning the deal could hurt competition and drive up healthcare costs in the Raleigh area. The post Is the Atrium-WakeMed Merger Already Hitting a Wall? appeared first…

Read More

The U.S. Government and Gavi, the Vaccine Alliance

This fact sheet examines Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in lower income countries, and explores the role the U.S. government plays in supporting the partnership.

Read More